Evgenii Shumilov

26PUBLICATIONS
101CO-AUTHORS
Biomechanical engineeringSolid tumoursAutoimmunityTime-series analysisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 01, 2026
Feasibility and safety of rapid glofitamab ramp-up.

|Jun 26, 2026
Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort.

|Jun 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases.

|Jun 03, 2026
Epcoritamab in Richter transformation: insights from a real-world case series.

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Pageof 5

Frequent Collaborators

7 joint publications

Ulrike Bacher

5 joint publications

Thomas Pabst

4 joint publications

Paolo Mazzeo

4 joint publications

Vladan Vucinic